A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Clinical trial NCT07772921 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07772921
- Sponsor
- Pfizer
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-24
- Primary completion
- 2029-06-12
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.